Pfizer Says Booster Strengthens Immune Response for Children 5 to 11news2022-04-14T22:14:31+00:00April 14th, 2022|The New York Times|
F.D.A. Allows Second Coronavirus Boosters for Everyone 50 and Oldernews2022-03-29T23:44:53+00:00March 29th, 2022|The New York Times|
Biden Administration Plans to Offer Second Booster Shots to Those 50 and Upnews2022-03-26T14:29:54+00:00March 26th, 2022|The New York Times|
Moderna to Seek Authorization of Its Coronavirus Vaccine for Young Childrennews2022-03-23T22:18:57+00:00March 23rd, 2022|The New York Times|
¿Por qué China no ha aprobado o desarrollado una vacuna de ARNm?news2022-02-18T21:19:19+00:00February 18th, 2022|The New York Times|
Why China Doesn’t Have an mRNA Vaccine for Covidnews2022-02-18T14:58:52+00:00February 18th, 2022|The New York Times|
¿Vacunar a los niños pequeños o esperar?news2022-02-11T18:08:17+00:00February 11th, 2022|The New York Times|
The Next Vaccine Debate: Immunize Young Children Now, or Wait?news2022-02-09T20:16:21+00:00February 9th, 2022|The New York Times|
F.D.A. Approves Remdesivir for Patients Not Hospitalizednews2022-01-22T16:58:04+00:00January 22nd, 2022|The New York Times|
F.D.A. Plans to Allow 12- to 15-Year-Olds to Receive Pfizer Boostersnews2021-12-31T02:43:34+00:00December 31st, 2021|The New York Times|